Owners, management and financials
CVR: 33963750
Secondary names: AntibioTx A/S
Previous names: SYNERCURE ApS, ANTIBIOTX ApS, AntibioTx A/S
DKK -11,802,644
Gross profit
Net result: DKK -32,142,051
MANJIN ApS (20-24,99%), VENDLER ApS (20-24,99%)
3 more
CVR · view owners
Kim Domela Kjøller, Morten Otto Alexander Sommer
1 more in management
Board: Stig Løkke Pedersen (chair) and 4 members
CVR · view management
Active
Founded 10 October 2011
CVR · view overview
11 employees
CVR · 2018
Director role ended: Morten Højland Boesen
CVR · 28/11/2025
View the full event history
UNION therapeutics A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AntibioTx A/S and ANTIBIOTX ApS. The management consists of Kim Domela Kjøller, Morten Otto Alexander Sommer and Rasmus Vendler Toft-Kehler. The board consists of Stig Løkke Pedersen (chair), Andrew John Oakley, Morten Otto Alexander Sommer and Peter Kristensen. The company's owners include MANJIN ApS, VENDLER ApS and T&W HOLDING A/S. The company has 11 employees (2018). In 2025, the company reported a gross profit of DKK -11,802,644 and a net result of DKK -32,142,051 compared with DKK -98,922,000 the year before. Equity in the 2025 report amounted to DKK -147,650,138.
Selskabets formål er at drive forsknings- og udviklingsvirksomhed inden for bioteknologi samt anden i forbindelse hermed stående virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | -32.1 mio. | 29.4 mio. | -147.7 mio. | 8 | |
| 202401/01/2024 – 31/12/2024 | 621 t. | -98.9 mio. | 61.2 mio. | -150.1 mio. | - | |
| 202301/01/2023 – 31/12/2023 | 2.3 mio. | -169.4 mio. | 120.2 mio. | -61.6 mio. | - | |
| 202201/01/2022 – 31/12/2022 | 34.4 mio. | -214.3 mio. | 185.7 mio. | -27.7 mio. | - | |
| 202101/01/2021 – 31/12/2021 | 118.9 mio. | -56 mio. | 284.9 mio. | 49.4 mio. | 26 | |
| 202001/01/2020 – 31/12/2020 | 0 | -80.9 mio. | 68.9 mio. | -58.4 mio. | - | |
| 201901/01/2019 – 31/12/2019 | 12 t. | -13 t. | 52.3 mio. | -38.3 mio. | - | |
| 201801/01/2018 – 31/12/2018 | 0 USD | -7.8 mio. USD | 4.4 mio. USD | -5.3 mio. USD | - | |
| 201701/01/2017 – 31/12/2017 | 315 t. USD | -5.4 mio. USD | 3.7 mio. USD | 1.9 mio. USD | - | |
| 201601/01/2016 – 31/12/2016 | 729 t. USD | -485 t. USD | 776 t. USD | -195 t. USD | - | |
| 201501/01/2015 – 31/12/2015 | 691 t. USD | -224 t. USD | 246 t. USD | -71 t. USD | - | |
| 201401/01/2014 – 31/12/2014 | - | 578 t. | 3.1 mio. | 988 t. | - | |
| 201301/01/2013 – 31/12/2013 | - | 359 t. | 1.8 mio. | 410 t. | - |
Compared to 1.040 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorThe CVR number of UNION therapeutics A/S is 33963750.
The owners of UNION therapeutics A/S include MANJIN ApS, VENDLER ApS and T&W HOLDING A/S.
The management of UNION therapeutics A/S consists of Kim Domela Kjøller, Morten Otto Alexander Sommer and Rasmus Vendler Toft-Kehler.
The board of UNION therapeutics A/S consists of Stig Løkke Pedersen, Andrew John Oakley and Morten Otto Alexander Sommer, with Stig Løkke Pedersen as chair.
In 2025, UNION therapeutics A/S reported a gross profit of DKK -11,802,644.
UNION therapeutics A/S had 11 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new email: [email protected], new website: www.uniontherapeutics.com (July 3, 2026).
Contact info changed: new email: [email protected], new website: www.uniontherapeutics.com (July 1, 2026).
UNION therapeutics A/S has published its annual report for 2025. Gross profit came to DKK -11,802,644, and the net result was DKK -32,142,051.
Contact info changed: new email: [email protected], new website: www.uniontherapeutics.com (June 19, 2026).
As of June 8, 2026, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of UNION therapeutics A/S.
As of June 8, 2026, EY Godkendt Revisionspartnerselskab has stepped down as auditor of UNION therapeutics A/S.
As of November 28, 2025, Morten Højland Boesen has stepped down as director of UNION therapeutics A/S.
UNION therapeutics A/S has published its annual report for 2024. Revenue came to DKK 621,000, and the net result was DKK -98,922,000.
As of March 26, 2025, Gitte Pugholm Aabo has left the board of directors of UNION therapeutics A/S.
As of March 26, 2025, Arthur Joseph Higgins has left the board of directors of UNION therapeutics A/S.
As of July 5, 2024, Peter Kristensen has joined the board of directors of UNION therapeutics A/S.
As of July 5, 2024, Jutta Monika Heim has left the board of directors of UNION therapeutics A/S.
UNION therapeutics A/S has published its annual report for 2023. Revenue came to DKK 2,299,000, and the net result was DKK -169,426,000.
As of December 5, 2023, MANJIN ApS is registered as an owner of UNION therapeutics A/S with an ownership share of 20%.
As of December 5, 2023, VENDLER ApS is registered as an owner of UNION therapeutics A/S with an ownership share of 20%.
As of July 13, 2023, T&W HOLDING A/S is registered as an owner of UNION therapeutics A/S with an ownership share of 5%.
UNION therapeutics A/S has published its annual report for 2022. Revenue came to DKK 34,393,000, and the net result was DKK -214,304,000.
UNION therapeutics A/S has published its annual report for 2021. Revenue came to DKK 118,912,000, and the net result was DKK -56,026,000.
As of August 31, 2021, Morten Otto Alexander Sommer is registered as director of UNION therapeutics A/S.
As of July 12, 2021, Gitte Pugholm Aabo has joined the board of directors of UNION therapeutics A/S.
As of July 12, 2021, Arthur Joseph Higgins has joined the board of directors of UNION therapeutics A/S.
UNION therapeutics A/S has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK -80,896,000.
As of January 1, 2021, Kim Domela Kjøller is registered as adm. dir. of UNION therapeutics A/S.
As of January 1, 2021, Morten Otto Alexander Sommer has stepped down as director of UNION therapeutics A/S.
UNION therapeutics A/S has published its annual report for 2019. Revenue came to DKK 11,649, and the net result was DKK -12,862.
As of February 28, 2020, Stig Løkke Pedersen has joined the board of directors of UNION therapeutics A/S.
As of February 28, 2020, Ole Skov has left the board of directors of UNION therapeutics A/S.
As of February 27, 2020, Stig Løkke Pedersen has left the board of directors of UNION therapeutics A/S.
UNION therapeutics A/S has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -7,798,346.
As of May 31, 2019, Andrew John Oakley has joined the board of directors of UNION therapeutics A/S.
On October 5, 2018, the company changed its name from AntibioTx A/S to UNION therapeutics A/S.
UNION therapeutics A/S has published its annual report for 2017. Revenue came to DKK 315,394, and the net result was DKK -5,396,630.
As of April 1, 2018, Morten Højland Boesen is registered as director of UNION therapeutics A/S.
As of June 23, 2017, Stig Løkke Pedersen has joined the board of directors of UNION therapeutics A/S.
As of June 23, 2017, Ole Skov has joined the board of directors of UNION therapeutics A/S.
As of June 23, 2017, Jutta Monika Heim has joined the board of directors of UNION therapeutics A/S.
As of June 23, 2017, Astrid Sommer has left the board of directors of UNION therapeutics A/S.
As of June 23, 2017, Anne Katrine Toft-Kehler has left the board of directors of UNION therapeutics A/S.
As of June 22, 2017, Ole Skov has left the board of directors of UNION therapeutics A/S.
UNION therapeutics A/S has published its annual report for 2016. Revenue came to DKK 728,695, and the net result was DKK -485,441.
As of June 1, 2017, Ole Skov has joined the board of directors of UNION therapeutics A/S.
As of June 1, 2017, Rasmus Vendler Toft-Kehler is registered as director of UNION therapeutics A/S.
As of May 31, 2017, Rasmus Vendler Toft-Kehler has stepped down as adm. dir. of UNION therapeutics A/S.
On May 31, 2017, the company changed its name from ANTIBIOTX ApS to AntibioTx A/S.
As of April 21, 2017, EAF Procedius K/S is registered as an owner of UNION therapeutics A/S with an ownership share of 5%.
As of April 21, 2017, Pharmaway Invest ApS is registered as an owner of UNION therapeutics A/S with an ownership share of 5%.
UNION therapeutics A/S has published its annual report for 2015. Revenue came to DKK 690,674, and the net result was DKK -223,943.
As of April 1, 2016, EY Godkendt Revisionspartnerselskab has been appointed auditor of UNION therapeutics A/S.
As of March 17, 2016, RSM PLUS P/S STATSAUTORISEREDE REVISORER has stepped down as auditor of UNION therapeutics A/S.
As of January 26, 2016, Rasmus Vendler Toft-Kehler has joined the board of directors of UNION therapeutics A/S.
As of January 26, 2016, Morten Otto Alexander Sommer has joined the board of directors of UNION therapeutics A/S.
As of January 26, 2016, Astrid Sommer has joined the board of directors of UNION therapeutics A/S.
As of January 26, 2016, Anne Katrine Toft-Kehler has joined the board of directors of UNION therapeutics A/S.
UNION therapeutics A/S has published its annual report for 2014. Gross profit came to DKK 3,055,657, and the net result was DKK 578,227.
UNION therapeutics A/S has published its annual report for 2013. Gross profit came to DKK 1,202,613, and the net result was DKK 359,099.
As of November 29, 2013, RVT REVISIONSTJENESTEN A/S has stepped down as auditor of UNION therapeutics A/S.
UNION therapeutics A/S has published its interim report for the period October 10, 2011 – December 31, 2012.
On May 29, 2013, the company changed its name from SYNERCURE ApS to ANTIBIOTX ApS.
As of February 12, 2013, RSM PLUS P/S STATSAUTORISEREDE REVISORER has been appointed auditor of UNION therapeutics A/S.
As of October 10, 2011, RVT REVISIONSTJENESTEN A/S has been appointed auditor of UNION therapeutics A/S.
As of October 10, 2011, Rasmus Vendler Toft-Kehler is registered as adm. dir. of UNION therapeutics A/S.
As of October 10, 2011, Morten Otto Alexander Sommer is registered as director of UNION therapeutics A/S.
UNION therapeutics A/S was founded on October 10, 2011.
Companies in the same industry and area
CVR 26392861
CVR 41366044
CVR 32971024
CVR 27701396
CVR 43932489
